Moritz Rapp

Moritz Rapp

Auto-generated profile, based on publicly available information

Moritz Rapp

Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Immunity
Verified
Journal Article
Closed access
TOTimothy E. O’sUllivan
Timothy E. O’sUllivan
MRMoritz Rapp
Moritz Rapp
XFXiying Fan
Xiying Fan
OWOrr-El Weizman
Orr-El Weizman
PBPriya Bhardwaj
Priya Bhardwaj
JSJoseph C. Sun
Joseph C. Sun

6 August 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CLColleen M. Lau
Colleen M. Lau
NANicholas M. Adams
Nicholas M. Adams
CGClair D. Geary
Clair D. Geary
OWOrr-El Weizman
Orr-El Weizman
MRMoritz Rapp
Moritz Rapp
JSJoseph C. Sun
Joseph C. Sun

25 March 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MRMoritz Rapp
Moritz Rapp
MWMaximilian W.M. Wintergerst
Maximilian W.M. Wintergerst
WKWolfgang G. Kunz
Wolfgang G. Kunz
VVViola K. Vetter
Viola K. Vetter
MKMax M.L. Knott
Max M.L. Knott
DADavid Anz
David Anz
Chemokines have crucial roles in organ development and orchestration of leukocyte migration. The chemokine CCL22 is expressed constitutively at high levels in the lymph node, but the functional significance of this expression is so far unknown. Studying a newly established CCL22-deficient mouse, we demonstrate that CCL22 expression by dendritic cells (DCs) promotes the formation of cell–cell contacts and interaction with regulatory T cells (T reg) through their CCR4 receptor. Vaccination of CCL22-deficient mice led to excessive T cell responses that were also observed when wild-type mice were vaccinated using CCL22-deficient DCs. Tumor-bearing mice with CCL22 deficiency showed prolonged survival upon vaccination, and further, CCL22-deficient mice had increased susceptibility to inflammatory disease. In conclusion, we identify the CCL22–CCR4 axis as an immune checkpoint that is crucial for the control of T cell immunity.

31 March 2011 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
CZChristine Zoglmeier
Christine Zoglmeier
HBHelen Bauer
Helen Bauer
DNDaniel Nörenberg
Daniel Nörenberg
GWGeorg Wedekind
Georg Wedekind
PBPhilipp Bittner
Philipp Bittner
CBCarole Bourquin
Carole Bourquin
Purpose: The Toll-like receptor (TLR) 9 ligand CpG has been used successfully for the immunotherapy of cancer. Chronic CpG application in tumor-free hosts leads, however, to the expansion of myeloid-derived suppressor cells (MDSC), which can cause T-cell suppression and may thus hamper the development of an effective immune response. Here, we investigated the effect of TLR9 activation on the function of MDSC in tumor-bearing mice.

11 January 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SMSharline Madera
Sharline Madera
MRMoritz Rapp
Moritz Rapp
MFMatthew A. Firth
Matthew A. Firth
JBJoshua N. Beilke
Joshua N. Beilke
LLLewis L. Lanier
Lewis L. Lanier
JSJoseph C. Sun
Joseph C. Sun
Type I interferon (IFN) is crucial in host antiviral defense. Previous studies have described the pleiotropic role of type I IFNs on innate and adaptive immune cells during viral infection. Here, we demonstrate that natural killer (NK) cells from mice lacking the type I IFN-α receptor (Ifnar−/−) or STAT1 (which signals downstream of IFNAR) are defective in expansion and memory cell formation after mouse cytomegalovirus (MCMV) infection. Despite comparable proliferation, Ifnar−/− NK cells showed diminished protection against MCMV infection and exhibited more apoptosis compared with wild-type NK cells. Furthermore, we show that Ifnar−/− NK cells express increased levels of NK group 2 member D (NKG2D) ligands during viral infection and are susceptible to NK cell–mediated fratricide in a perforin- and NKG2D-dependent manner. Adoptive transfer of Ifnar−/− NK cells into NK cell–deficient mice reverses the defect in survival and expansion. Our study reveals a novel type I IFN–dependent mechanism by which NK cells evade mechanisms of cell death after viral infection.

1 June 2018 in Immunity
Verified
Journal Article
Closed access
NANicholas M. Adams
Nicholas M. Adams
CLColleen M. Lau
Colleen M. Lau
XFXiying Fan
Xiying Fan
MRMoritz Rapp
Moritz Rapp
CGClair D. Geary
Clair D. Geary
JSJoseph C. Sun
Joseph C. Sun